9 April 2021 - The FDA's review process will probably take several weeks, experts say. The move would make Pfizer's vaccine available to the widest age range.
Pfizer on Friday requested to expand use of its COVID-19 vaccine to adolescents ages 12 to 15.
The request asks the Food and Drug Administration to amend the emergency use authorisation, which the FDA originally granted late last year for people ages 16 and up.